You achieve return of spontaneous circulation after cardiac arrest. Your patient remains comatose. You know temperature control can improve neurological outcomes and survival. But what temperature should you target? How quickly should you cool? When do you rewarm? These questions matter because the decisions you make in the next few hours directly affect your patient’s chance of meaningful recovery.
Current evidence shows that preventing fever and maintaining controlled temperature between 32°C and 37.5°C for at least 24 hours after arrest improves outcomes. Yet many clinicians lack a clear, practical protocol to implement this intervention safely. You need a system that works in your clinical setting, whether you’re in a tertiary ICU or a smaller regional hospital.
This guide walks you through seven steps to implement targeted temperature management after cardiac arrest. You’ll learn how to confirm eligibility, select your temperature target, prepare your team and equipment, induce cooling safely, monitor for complications, rewarm without causing harm, and document your approach. Each step includes specific actions, monitoring parameters, and troubleshooting advice you can apply immediately in your practice.
Why temperature control matters after arrest
Your patient’s brain faces ongoing injury for hours and days after you restore circulation. The initial ischaemic insult during arrest triggers a cascade of secondary damage that continues well into the post-resuscitation phase. Cerebral hyperthermia amplifies this injury, whilst controlled temperature management interrupts the destructive cycle. Understanding why temperature matters helps you recognise this intervention as essential care, not optional.
The cascade of brain injury after arrest
Return of spontaneous circulation doesn’t stop neuronal death. Reperfusion injury begins immediately as oxygen-rich blood floods previously ischaemic tissue, generating free radicals and triggering inflammatory cascades. Excitotoxic neurotransmitters like glutamate accumulate, calcium floods into cells, and mitochondrial dysfunction spreads through tissue. This secondary injury phase determines whether your patient wakes up neurologically intact or remains severely disabled.
Temperature directly controls the speed of these destructive processes. Every 1°C increase above 37°C accelerates cerebral metabolism by approximately 7%, driving faster accumulation of toxic metabolites, increased oxygen demand in already compromised tissue, and heightened inflammatory responses. Studies show that patients who develop fever in the first 48 hours after arrest experience worse neurological outcomes and higher mortality, even when other factors remain equal.
How controlled temperature protects neurons
A targeted temperature management protocol works through multiple protective mechanisms. Hypothermia between 32°C and 34°C reduces cerebral metabolic rate by 6% to 7% per degree, buying time for cells to recover from ischaemic injury. Lower temperatures suppress glutamate release, reduce free radical production, stabilise cell membranes, and decrease the inflammatory response that damages neurons hours after the initial insult.
Even maintaining normothermia at 36°C to 37.5°C without deeper cooling provides benefit. Preventing fever alone improves survival and neurological outcomes compared to uncontrolled temperature management. The 2021 TTM2 trial demonstrated similar outcomes between 33°C and a strictly controlled 37.5°C target, suggesting that the critical factor may be avoiding hyperthermia rather than achieving deep hypothermia.
The cost of uncontrolled fever
Fever develops in 40% to 70% of post-arrest patients when you don’t actively control temperature. Each hour of fever above 37.5°C correlates with worse neurological recovery and increased mortality at six months. The damage compounds because fever combines multiple harmful effects: increased metabolic demand, enhanced inflammatory signalling, disrupted blood-brain barrier integrity, and accelerated neuronal apoptosis.
Maintaining controlled temperature for at least 72 hours prevents the rebound hyperthermia that commonly follows initial cooling and continues to protect vulnerable neurons throughout the critical recovery window.
You cannot predict which patients will develop harmful fever. Active temperature control removes this uncertainty and ensures every comatose post-arrest patient receives consistent neuroprotection during their most vulnerable period.
Step 1. Confirm eligibility and contraindications
Before initiating any targeted temperature management protocol, you must systematically assess whether your patient qualifies for this intervention and identify any factors that might cause harm. Temperature control benefits comatose survivors of cardiac arrest, but not every post-arrest patient requires or tolerates induced hypothermia. This first step prevents you from applying cooling to patients who won’t benefit or who face unacceptable risks, whilst ensuring eligible patients receive this life-saving intervention promptly.
Who qualifies for temperature control
Your patient qualifies for targeted temperature management if they remain comatose after achieving sustained return of spontaneous circulation following cardiac arrest. Comatose means they don’t obey verbal commands and have a Glasgow Coma Scale score of 8 or less despite adequate time for sedation to wear off (typically 20 to 30 minutes after restoration of circulation).
Both shockable rhythms (ventricular fibrillation, pulseless ventricular tachycardia) and non-shockable rhythms (asystole, pulseless electrical activity) qualify for temperature control. Out-of-hospital and in-hospital cardiac arrests both meet eligibility criteria. The arrest aetiology (cardiac versus non-cardiac) doesn’t exclude patients, though evidence remains strongest for cardiac causes.
Absolute contraindications to cooling
You must not implement hypothermic temperature control (32°C to 34°C) when your patient has active uncontrolled bleeding that requires urgent surgical intervention. Hypothermia impairs coagulation, prolongs bleeding time, and increases transfusion requirements. Patients with haemorrhagic stroke, major trauma with ongoing bleeding, or recent surgery with active haemorrhage should receive fever prevention only (maintaining temperature at or below 37.5°C) rather than induced hypothermia.
Pre-existing severe coagulopathy (INR > 1.8, platelets < 50 × 10⁹/L) represents another absolute contraindication to hypothermic targets. Cardiac arrest from trauma requires different protocols focused on haemorrhage control and damage limitation rather than cooling. Already conscious patients (responding to commands, following instructions) don’t require temperature control because their neurological recovery is already evident.
Relative contraindications requiring careful assessment
Several conditions demand individualised risk-benefit assessment before proceeding with hypothermia below 36°C. Severe refractory hypotension (systolic blood pressure < 80 mmHg despite adequate fluid resuscitation and high-dose vasopressors) may worsen with cooling, as hypothermia causes vasoconstriction and can reduce cardiac output. You can still implement fever prevention in these patients whilst addressing haemodynamic instability.
Active sepsis or severe infection increases your patient’s vulnerability to immune suppression from hypothermia. Consider maintaining normothermia (36°C to 37.5°C) rather than deeper cooling if infection preceded the arrest. Pregnancy poses unique challenges; whilst not an absolute contraindication, hypothermia affects both maternal and foetal physiology, requiring obstetric consultation before implementing your targeted temperature management protocol.
Patients with pre-existing hypothermia (core temperature < 35°C) on admission should not be actively warmed to normothermia; instead, allow passive rewarming whilst preventing fever above 37.5°C.
Document your eligibility assessment and any contraindications clearly in the medical record before proceeding to temperature target selection. This documentation supports clinical decision-making and provides audit trail for quality improvement.
Step 2. Decide your target temperature strategy
Your choice of temperature target shapes every downstream decision in your targeted temperature management protocol. Current evidence supports two approaches: hypothermic temperature control (32°C to 34°C) or normothermic temperature control (36°C to 37.5°C). Both strategies prevent fever and improve outcomes compared to uncontrolled temperature management, but each carries distinct implementation requirements and physiological trade-offs that affect your patient’s care pathway.
Understanding the evidence base
The landmark 2002 studies established hypothermia at 33°C for 24 hours as the gold standard, demonstrating significant improvements in neurological outcomes and survival. These trials shaped practice for nearly two decades and remain valid evidence for hypothermic targets. However, the 2021 TTM2 trial challenged this paradigm by comparing 33°C with strictly controlled 37.5°C in 1,900 patients and finding no difference in mortality or neurological outcomes at six months.
This evidence doesn’t prove hypothermia fails to work. TTM2 demonstrated that rigorous fever prevention at 37.5°C produces similar benefits to deeper cooling, suggesting the primary mechanism of benefit lies in avoiding hyperthermia rather than achieving profound metabolic suppression. Both temperature targets in TTM2 received active, protocol-driven control for 72 hours, eliminating the fever spikes that damage recovering neurons.
Weighing hypothermic versus normothermic strategies
Hypothermic targets (32°C to 34°C) offer theoretical advantages through greater metabolic suppression and potentially stronger neuroprotection. You achieve more profound reduction in cerebral oxygen consumption and inflammatory mediators with deeper cooling. However, hypothermia increases your patient’s risk of bradycardia, coagulopathy, immune suppression, and electrolyte disturbances. Implementation requires more intensive monitoring, aggressive shivering management with sedation and paralysis, and careful attention to haemodynamic support.
Normothermic targets (36°C to 37.5°C) provide reliable neuroprotection whilst avoiding complications associated with deeper cooling. Your patient maintains better haemodynamic stability, requires less sedation, faces lower infection risk, and tolerates the intervention more predictably. Rewarming occurs faster and carries less risk of electrolyte rebound. Normothermia suits resource-limited settings where intensive monitoring or advanced cooling devices aren’t readily available.
Australian and New Zealand resuscitation guidelines suggest actively preventing fever by targeting temperature ≤37.5°C for all comatose post-arrest patients, whilst acknowledging that some subpopulations may benefit from hypothermic targets at 32°C to 34°C.
Making your clinical decision
Select your temperature target based on your patient’s clinical characteristics, your institutional resources, and your team’s experience. Consider hypothermic targets (33°C) for younger patients with witnessed arrests, short down-times, and shockable initial rhythms who have the greatest potential for good neurological recovery. Choose this approach when you have reliable temperature control devices, experienced staff, and robust protocols for managing complications.
Opt for normothermic targets (36°C to 37.5°C) for patients with prolonged arrests, significant comorbidities, or relative contraindications to deeper cooling. This strategy works well in centres beginning their temperature management programme or in settings with limited access to advanced cooling technology. Document your chosen target temperature and your clinical rationale clearly in the medical record before proceeding to patient preparation.
Step 3. Prepare the patient, team and equipment
Successful temperature control starts before you apply a single cooling device. Your patient requires optimal baseline stability and your team needs clear role assignments before initiating your targeted temperature management protocol. This preparation phase prevents complications, ensures smooth implementation, and allows you to focus on temperature control rather than troubleshooting basic issues during cooling.
Securing airway and vascular access
Your comatose patient needs definitive airway protection before you begin cooling. Endotracheal intubation with mechanical ventilation prevents aspiration, allows precise control of oxygenation and ventilation, and facilitates sedation required for shivering suppression. Set your ventilator to maintain oxygen saturation between 94% and 98% and PaCO₂ between 35 and 45 mmHg, avoiding both hyperoxia and hypocapnia that compromise cerebral perfusion.
Establish adequate vascular access before cooling begins. Place at least two large-bore peripheral intravenous cannulas (16-gauge or larger) for fluid administration and medication delivery. Insert a central venous catheter if you plan to use intravascular cooling devices or if your patient requires high-dose vasopressor support. Arterial line placement enables continuous blood pressure monitoring and facilitates frequent blood sampling throughout the cooling, maintenance, and rewarming phases.
Assembling your cooling equipment
Select your cooling method based on available resources and your chosen temperature target. Surface cooling devices (water-circulating blankets, gel pads, or forced-air systems) work reliably for both hypothermic and normothermic targets. Intravascular cooling catheters provide tighter temperature control with less overshoot but require central venous access and involve catheter-related risks.
Ensure your temperature monitoring probe reaches true core temperature; esophageal probes offer the fastest response time (3 to 10 minute lag), whilst bladder probes provide convenience with acceptable accuracy (15 to 20 minute lag).
Prepare adjunctive cooling supplies if using conventional methods: ice packs for axillae and groins, cold intravenous fluid (4°C normal saline), and additional blankets for counter-warming of hands and face to reduce shivering threshold.
Pre-cooling checklist
Complete these tasks before initiating cooling:
- Baseline assessment: Document neurological status, obtain arterial blood gas, measure electrolytes (potassium, magnesium, phosphate, calcium), and record vital signs
- Monitoring setup: Continuous ECG, arterial line transduced, temperature probe positioned, urinary catheter inserted with hourly output measurement
- Medication preparation: Sedatives ready (propofol or midazolam), analgesics available (fentanyl), neuromuscular blockers accessible if needed
- Team briefing: Assign roles for temperature monitoring, shivering assessment, blood sampling, and documentation
- Protocol confirmation: Target temperature documented, duration specified (24 hours minimum), rewarming rate agreed (0.2°C to 0.5°C per hour)
Your systematic preparation prevents delays, reduces complications, and allows smooth transition into the cooling phase.
Step 4. Induce and maintain temperature control
You now transition from preparation to active intervention. The induction phase aims to reach your target temperature as quickly as possible, typically within 2 to 4 hours, whilst the maintenance phase sustains this temperature for at least 24 hours. Your technique, monitoring frequency, and response to shivering determine whether your patient receives consistent neuroprotection or experiences harmful temperature fluctuations that reduce benefit.
Choose your cooling method
Start cooling immediately after completing your preparation checklist. Infuse 30 mL/kg of cold normal saline (4°C) over 20 to 30 minutes as your initial intervention, regardless of which cooling device you plan to use. This rapidly reduces core temperature by 1°C to 1.5°C and requires no special equipment beyond refrigerated fluid. Calculate the volume (a 70 kg patient receives 2,100 mL) and monitor for fluid overload in patients with cardiac dysfunction.
Apply your chosen surface cooling device or insert your intravascular catheter during cold fluid infusion. Water-circulating blankets work best when you position them above and below the patient, maximising surface contact area. Gel-coated adhesive pads attach to chest, back, and thighs without requiring additional blankets. Set your device to your target temperature and enable feedback mode if available, allowing automated adjustment based on continuous core temperature readings.
Induce hypothermia rapidly
Monitor core temperature every 15 minutes during induction using your esophageal or bladder probe. Record each reading on a dedicated temperature chart that tracks time, temperature, cooling method adjustments, and any shivering episodes. Your cooling rate should average 0.5°C to 1.5°C per hour depending on method (intravascular catheters cool fastest, conventional methods slowest).
Anticipate and suppress shivering before it starts. Begin sedation with propofol (25 to 75 mcg/kg/min) or midazolam (0.05 to 0.2 mg/kg/hour) as soon as you initiate cooling. Add fentanyl (25 to 100 mcg/hour) for analgesia. Assess shivering using the Bedside Shivering Assessment Scale every 30 minutes:
| BSAS Score | Clinical Finding | Response Required |
|---|---|---|
| 0 | No shivering | Continue current regimen |
| 1 | Mild fasciculations (no gross movements) | Increase sedation 25% |
| 2 | Moderate shivering (one area only) | Add counter-warming, escalate sedation |
| 3 | Severe shivering (multiple areas) | Consider neuromuscular blockade |
Apply counter-warming devices to hands, feet, and face when shivering persists despite adequate sedation; this raises peripheral temperature and lowers the shivering threshold without affecting core cooling.
Maintain target temperature
Once you reach your target temperature, adjust your cooling device to maintenance mode. Check core temperature hourly throughout the 24-hour maintenance period (minimum duration). Your temperature should remain within ±0.5°C of target; deviations beyond this range indicate inadequate device function or insufficient shivering control.
Document temperature, vital signs, and neurological status every hour using your ICU observation chart. Note any episodes of overshoot (temperature below target by >1°C), which require temporarily stopping cooling and allowing passive rewarming. Resume cooling when temperature rises to 0.5°C above target. Adjust sedation based on ongoing shivering assessments rather than maintaining fixed doses throughout maintenance.
Measure electrolytes (potassium, magnesium, phosphate) every 6 hours during maintenance. Hypothermia drives these ions intracellularly, requiring frequent replacement to maintain normal serum levels. Continue your targeted temperature management protocol for the full 24 hours before proceeding to controlled rewarming.
Step 5. Monitor, troubleshoot and support organs
Your patient remains vulnerable to multiple physiological derangements throughout the cooling and maintenance phases. Temperature control affects every organ system, and complications develop silently unless you maintain systematic surveillance. This step requires hourly assessment of cardiovascular function, electrolyte balance, and organ perfusion, combined with rapid intervention when parameters drift outside safe ranges.
Track cardiovascular stability
Hypothermia predictably alters haemodynamic parameters within the first few hours of cooling. Your patient’s heart rate decreases by approximately 20% to 25% as temperature drops, with sinus bradycardia (heart rate 40 to 50 beats per minute) representing a normal response rather than pathology. Maintain continuous ECG monitoring to distinguish benign bradycardia from dangerous arrhythmias like complete heart block or ventricular ectopy.
Measure blood pressure invasively every hour using your arterial line, targeting mean arterial pressure above 65 mmHg. Cooling causes peripheral vasoconstriction that increases systemic vascular resistance, sometimes elevating blood pressure despite reduced cardiac output. Calculate cardiac output using your central venous catheter if available, particularly when initiating vasopressor therapy. Noradrenaline remains the first-line vasopressor during hypothermia, starting at 0.05 mcg/kg/min and titrating to effect.
Monitor for QT interval prolongation on your ECG strip every 4 hours; prolongation beyond 500 milliseconds increases your patient’s risk of torsades de pointes and requires correction of electrolytes before further cooling.
Manage electrolyte disturbances
Temperature control drives potassium, magnesium, and phosphate into cells, creating serum deficits that require aggressive replacement. Measure electrolytes every 6 hours during maintenance and replace according to this protocol:
| Electrolyte | Target Range | Replacement Protocol |
|---|---|---|
| Potassium | 4.0 to 5.0 mmol/L | 20 mmol IV over 2 hours if <3.5 mmol/L |
| Magnesium | 1.0 to 1.5 mmol/L | 10 mmol IV over 30 minutes if <0.8 mmol/L |
| Phosphate | 0.8 to 1.5 mmol/L | 20 mmol IV over 4 hours if <0.6 mmol/L |
| Calcium | 2.1 to 2.6 mmol/L | 10 mmol calcium gluconate IV if <1.9 mmol/L |
Recheck serum levels 2 hours after each replacement dose to confirm adequate correction. Your patient may require repeated supplementation throughout maintenance because hypothermia continues driving ions intracellularly. Document all replacement doses and subsequent levels on your ICU flow chart to track trends and adjust your targeted temperature management protocol accordingly.
Support renal and respiratory function
Monitor urine output hourly, expecting cold-induced diuresis producing 1.5 to 3 mL/kg/hour during the first 6 hours of cooling. Replace urinary losses with normal saline to prevent hypovolemia, adjusting fluid rates based on central venous pressure and lactate trends. Reduce replacement fluids after 6 hours when diuresis typically resolves.
Adjust ventilator settings every 4 hours based on arterial blood gas results. Hypothermia reduces CO₂ production by 7% per degree Celsius, requiring lower minute ventilation to maintain normocapnia. Decrease respiratory rate rather than tidal volume to prevent iatrogenic hypocapnia. Maintain PaO₂ between 80 and 100 mmHg, avoiding hyperoxia that generates harmful free radicals.
Identify and treat complications
Watch for these red flags requiring immediate intervention:
- Core temperature <31°C: Stop cooling immediately, apply passive rewarming, increase sedation
- Systolic blood pressure <80 mmHg despite fluids: Escalate noradrenaline, consider adding vasopressin 0.03 units/min
- New arrhythmia (atrial fibrillation, ventricular ectopy): Check and correct electrolytes, review QT interval, consider amiodarone if sustained
- Declining urine output (<0.5 mL/kg/hour): Fluid bolus 250 mL, reassess volume status, measure bladder pressure for abdominal compartment syndrome
- Rising lactate despite adequate perfusion: Exclude occult bleeding, review sedation depth, ensure adequate oxygen delivery
Escalate to senior clinicians when complications persist despite your initial interventions or when multiple organ systems deteriorate simultaneously.
Step 6. Rewarm safely and prevent rebound fever
Rewarming represents the most dangerous phase of your targeted temperature management protocol. Rapid temperature rise triggers electrolyte shifts, particularly potassium moving from cells back into serum, whilst rebound hyperthermia after reaching normothermia negates the neuroprotective benefits you worked to achieve. You must control rewarming speed, monitor for complications, and actively prevent fever for at least 48 hours after your patient reaches 36°C.
Start controlled rewarming at 24 hours
Begin active rewarming after maintaining your target temperature for 24 hours (extend to 48 hours if your institutional protocol specifies longer duration). Set your cooling device to increase temperature by 0.2°C to 0.5°C per hour, selecting the slower rate for patients who experienced complications during maintenance or who have significant electrolyte disturbances. Calculate your expected rewarming duration: a patient at 33°C requires 6 to 15 hours to reach 36°C depending on your chosen rate.
Monitor core temperature every 30 minutes during active rewarming using the same probe position throughout your protocol. Document each reading on your temperature chart and verify your device maintains the programmed rate. If temperature rises faster than 0.5°C per hour, stop active rewarming and allow passive temperature drift until rate slows, then resume controlled heating. Continue sedation and analgesia during rewarming because rapid temperature changes trigger discomfort and shivering even during warming phases.
Monitor electrolytes during temperature rise
Check potassium, magnesium, phosphate, and calcium levels every 2 hours throughout rewarming. Potassium poses the greatest risk because the intracellular shift that occurred during cooling reverses rapidly, potentially causing dangerous hyperkalaemia. Stop all potassium supplementation when you begin rewarming and prepare calcium gluconate (10 mmol drawn up ready) in case cardiac toxicity develops.
Measure serum potassium immediately if you observe peaked T waves, widened QRS complexes, or new arrhythmias during rewarming. Treat hyperkalaemia urgently if potassium exceeds 6.5 mmol/L or if ECG changes appear: give 10 mmol calcium gluconate IV over 2 minutes, followed by 10 units insulin with 25 grams glucose, and consider salbutamol 10 to 20 mg nebulised. Initiate renal replacement therapy for refractory hyperkalaemia unresponsive to medical management.
Slow rewarming at 0.2°C per hour allows your patient’s kidneys more time to excrete excess potassium, reducing the risk of dangerous hyperkalaemia spikes that trigger fatal arrhythmias.
Prevent rebound fever after reaching normothermia
Your neuroprotection work continues after reaching 36°C. Leave your cooling device in place and active for at least 48 hours after rewarming completes, setting the target to 37°C to prevent fever. Studies show rebound hyperthermia develops in 40% of patients within 12 hours of discontinuing temperature control, eliminating the neurological benefits you achieved through 24 hours of careful management.
Measure core temperature every 2 hours for 72 hours after rewarming and treat any reading above 37.5°C as harmful fever requiring intervention. Resume active cooling if temperature exceeds 37.5°C, give paracetamol 1 gram IV every 6 hours, and continue until 72 hours post-arrest. Only then can you safely discontinue active temperature monitoring and management, transitioning to standard ICU fever protocols.
Step 7. Review, document and refine your protocol
Your targeted temperature management protocol improves through systematic review of every case you manage. Documentation creates the audit trail you need to identify gaps, measure compliance, and demonstrate outcomes to your clinical governance committee. Quality improvement requires data, not assumptions, about how your protocol performs in real clinical practice.
Document every case systematically
Create a standardised data collection form for each patient receiving temperature control. Record eligibility assessment, including initial rhythm, time to return of spontaneous circulation, Glasgow Coma Scale score, and any contraindications identified. Document your target temperature selection and clinical rationale for choosing hypothermic versus normothermic control.
Track key process measures throughout treatment:
| Process Measure | Documentation Required |
|---|---|
| Time from ROSC to cooling initiation | Minutes elapsed, barriers identified |
| Temperature induction rate | Time to reach target, method used |
| Temperature stability | Hours within ±0.5°C of target |
| Complications | Arrhythmias, electrolyte disturbances, infections |
| Rewarming rate | Degrees per hour, overshoot episodes |
| Fever prevention duration | Hours maintained below 37.5°C post-rewarming |
Capture outcome data at hospital discharge and six months post-arrest: survival, Cerebral Performance Category score, and Modified Rankin Scale score. Store all documentation in a dedicated database that allows you to analyse trends across multiple patients.
Conduct quarterly protocol audits
Schedule formal protocol reviews every three months with your intensive care unit team. Calculate your compliance rate for key bundle elements: time to cooling initiation under 4 hours, temperature maintained within target range for 24 hours minimum, rewarming rate between 0.2°C and 0.5°C per hour, and fever prevention continued for 72 hours.
Identify barriers when compliance falls below 90% for any element. Common issues include delayed recognition of eligibility, equipment unavailable when needed, unclear role assignments during induction, and premature discontinuation of active temperature control. Root cause analysis reveals whether you need protocol simplification, staff education, equipment procurement, or system redesign.
Track your centre’s survival with good neurological outcome rate over time; improvement validates your protocol refinements, whilst stagnant outcomes signal the need for more substantial changes.
Benchmark your outcomes against published trials and national registries. Share your audit results with referring hospitals and ambulance services to improve the entire chain of post-arrest care in your region.
Next steps in your practice
You now have a systematic approach to implement temperature control after cardiac arrest. Start by reviewing your current institutional protocol against the seven steps outlined here, identifying gaps in eligibility assessment, monitoring frequency, or rewarming procedures that need strengthening. Share this framework with your intensive care unit team during your next educational meeting to ensure everyone follows consistent practice.
Temperature management represents just one component of comprehensive post-resuscitation care. Your patients benefit most when you combine controlled temperature with optimal haemodynamic support, early coronary intervention when indicated, and systematic neurological prognostication. Mastering these integrated skills requires ongoing education and practice.
Advance your resuscitation skills through our nationally accredited ALS courses to build confidence in managing cardiac arrest survivors from initial resuscitation through critical care. Regular training ensures you stay current with evolving evidence and maintain the competence needed to deliver protocol-driven care that saves lives.
